LAURUSLABSLaurus LabsLAURUSLABS info
$5.57info-3.91%24h
Global rank3976
Market cap$3.00B
Change 7d-2.84%
YTD Performance8.21%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Laurus Labs (LAURUSLABS) Stock Overview

    Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

    LAURUSLABS Stock Information

    Symbol
    LAURUSLABS
    Address
    Serene ChambersHyderabad, 500034India
    Founded
    -
    Trading hours
    -
    Website
    https://www.lauruslabs.com
    Country
    🇮🇳 India
    Phone Number
    91 40 3980 4333

    Laurus Labs (LAURUSLABS) Price Chart

    -
    Value:-

    Laurus Labs Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $5.57
    N/A
    Market Cap
    $3.00B
    N/A
    Shares Outstanding
    538.97M
    N/A
    Employees
    5.75K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org